Benelli, Roberto <br/><br/>
The chemopreventive retinoid 4HPR impairs prostate cancer cell migration and invasion by interfering with FAK/AKT/GSK3beta pathway and beta-catenin stability.  [electronic resource] 

 -  Molecular cancer  Jun 2010 
 - 142 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-4598 
<br/><br/><label>Standard No.: </label>10.1186/1476-4598-9-142  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticarcinogenic Agents--pharmacology<br/>Blotting, Western<br/>Bone Morphogenetic Protein 2--biosynthesis<br/>Cell Line, Tumor<br/>Fenretinide--pharmacology<br/>Focal Adhesion Protein-Tyrosine Kinases--metabolism<br/>Gene Silencing<br/>Glycogen Synthase Kinase 3--metabolism<br/>Glycogen Synthase Kinase 3 beta<br/>Humans<br/>Male<br/>Neoplasm Invasiveness<br/>Neoplasm Metastasis<br/>Prostatic Neoplasms--enzymology<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>beta Catenin--genetics